People · Operator
Named in public records as an officer, director or promoter · active 2019–2024 · Biotech / Pharma, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mantra Bio, Inc. | — | Biotech / Pharma | Series B | $30.1M | $1.1B | 2019 |
| Acelot, Inc. | — | Other | Series A | $8.7M | $35.6M | 2024 |
Catherine Planey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Catherine Planey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Francisco Gimenez | 1 | 7 |
| Ed O'Sullivan | 1 | 1 |
| Ambuj Singh | 1 | 1 |
| Michael Duca | 1 | 1 |
| Alexander Mok | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.